APOE and hyperlipoproteinemia type 3: It is well known that all patients with type III hyperlipidemia (dysbetalipoproteinemia) were APOE ε2 homozygous, whereas most ε2/ε2 subjects (>90%) were normolipidemic or even hypolipidemic, owing to reductions in LDL or HDL or both.